Human Molecular Genetics Advance Access published online on February 5, 2004
Human Molecular Genetics, doi:10.1093/hmg/ddh076
© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Genetics and Pathology, Section for Medical Genetics, Rudbeck Laboratory, Uppsala University. Dag Hammarskjölds väg 20, 751 85, Uppsala
* To whom correspondence should be addressed. E-mail: marta.alarcon{at}genpat.uu.se.
Systemic Lupus Erythematosus (SLE) is a chronic rheumatic disease with an autoimmune etiology. Nuclear components of the cells are the main targets of the autoimmune reaction, affecting virtually any organ in the body. SLE is also called a prototype disease due to a substantial overlap in its clinical symptoms with other autoimmune diseases. Therefore the understanding of the mechanisms underlying SLE may contribute to advances in studies and development of new treatments for several autoimmune diseases. SLE is a complex disease with both genetic factors (mutations or susceptibility alleles) and environmental factors (infections, drugs, stress, exposures, etc) contributing to its development. In this article we will give an overview of the latest findings in genetics of SLE, concentrating on the two most interesting and promising pathways: the PD-1 and the interferon (IFN) pathways.
Article
The Genetic Basis of Systemic Lupus Erythematosus - knowledge of today and thoughts for tomorrow
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. C. Fossey, C. L. Vnencak-Jones, N. J. Olsen, S. Sriram, G. Garrison, X. Deng, P. S. Crooke III, and T. M. Aune Identification of Molecular Biomarkers for Multiple Sclerosis J. Mol. Diagn., April 1, 2007; 9(2): 197 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hitomi, N. Tsuchiya, A. Kawasaki, J. Ohashi, T. Suzuki, C. Kyogoku, T. Fukazawa, S. Bejrachandra, U. Siriboonrit, D. Chandanayingyong, et al. CD72 polymorphisms associated with alternative splicing modify susceptibility to human systemic lupus erythematosus through epistatic interaction with FCGR2B Hum. Mol. Genet., December 1, 2004; 13(23): 2907 - 2917. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schotte, M. Gaubitz, P. Willeke, N. Tidow, G. Assmann, W. Domschke, and B. Schluter Interleukin-10 promoter microsatellite polymorphisms in systemic lupus erythematosus: association with the anti-Sm immune response Rheumatology, November 1, 2004; 43(11): 1357 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Farrall Quantitative genetic variation: a post-modern view Hum. Mol. Genet., April 1, 2004; 13(90001): R1 - 7. [Abstract] [Full Text] [PDF] |
||||


